Market Place
Sourcing Support
Massive Bio Partners with ACS on Cancer Trials
18 Nov 2025 //
BUSINESSWIRE
Massive Bio Calls on Congress to Classify ClinicalTrials.gov
17 Oct 2025 //
PHARMIWEB
Massive Bio Launches Cerner App to Speed Clinical Trial Match
28 Aug 2025 //
BUSINESSWIRE
Massive Bio, Prognos Health Partner to Broaden Oncology Access
12 Aug 2025 //
BUSINESSWIRE
Massive Bio Featured on CB Insights AI Drug R&D Market Map
05 Jun 2025 //
BUSINESSWIRE
Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO
30 May 2025 //
BUSINESSWIRE
Massive Bio Receives CNIL Certification for GDPR Compliance
14 Apr 2025 //
BUSINESSWIRE
Flatiron, Massive Bio Partner to Boost Patient ID
07 Apr 2025 //
BUSINESSWIRE
Massive Bio Pushes Cancer Research Amid NIH Funding Uncertainty
11 Feb 2025 //
BUSINESSWIRE
Massive Bio Earns Recognition For Cancer Research Innovation
15 Jan 2025 //
BUSINESSWIRE
Massive Bio, Mika Leverage AI, NGS For Cancer Patient Empowerment
02 Jun 2024 //
BUSINESSWIRE
Massive Bio`s Drug Utilization Optimizer At ASCO 2024
01 Jun 2024 //
BUSINESSWIRE
PCC, Massive Bio: Largest Multi-Sponsor Clinical Trial Matching Validation
28 May 2024 //
BUSINESSWIRE
Massive Bio Unveils AI Oncology/Hematology Platform At ASCO
07 May 2024 //
BUSINESSWIRE
Trialbee, Massive Bio link to match cancer patients with trials
01 Feb 2024 //
BIOSPACE
Trialbee and Massive Bio Join Forces to Improve Clinical Trial Access
31 Jan 2024 //
BUSINESSWIRE
Massive Bio and ONCOassist® Announce Strategic Partnership at ESMO 2023
19 Oct 2023 //
BUSINESSWIRE
Cancer initiative picks Massive Bio for patient trial matching
07 Jun 2023 //
FIERCE BIOTECH
Massive Bio & TOI Forge Partnership to Revolutionize AI-enabled Cancer Research
03 Jun 2023 //
BUSINESSWIRE
Precision Cancer Consortium Teams Up with Massive Bio
02 Jun 2023 //
BUSINESSWIRE
Massive Bio Launches Revolutionary ChatGPT-Powered Chatbot Platform
01 Jun 2023 //
BUSINESSWIRE
Clinical Trials Demystified by Massive Bio’s Chief Medical Officer
28 Feb 2023 //
BUSINESSWIRE
Massive Bio Announces Plans to Expand AI Use in Oncology
04 Jan 2023 //
BUSINESSWIRE
Massive Bio Adds Two New Executives to Its C-Suite
16 Dec 2022 //
CONTRACTPHARMA
Massive Bio Reaffirms Global Growth Strategy with Key C-Suite Hires
15 Dec 2022 //
BUSINESSWIRE
Massive Bio, Azra AI partner to boost cancer trial enrollment
14 Nov 2022 //
FIERCEBIOTECH
Massive Bio Onboards Over 100,000 Cancer Patients to Find Their Clinical Trial
26 Oct 2022 //
BUSINESSWIRE
Massive Bio Nominated for Prestigious Digital Health Award
07 Oct 2022 //
BUSINESSWIRE
Massive Bio & Perthera.ai Partner to Empower Cancer Patients with Therapies
05 Oct 2022 //
BUSINESSWIRE
Massive Bio expands European operations with 3 new hires
29 Sep 2022 //
FIERCEBIOTECH
AdhereTech, Massive Bio Announce AI-Enabled, Patient-Centric Oncology Solutions
07 Jun 2022 //
BUSINESSWIRE
Massive Bio Raises $9M to Scale Growth and Fuel Global Expansion
02 Jun 2022 //
BUSINESSWIRE
Massive Bio and Amber Specialty Pharmacy Announce Nationwide Partnership
03 May 2022 //
BUSINESSWIRE
Massive Bio to Partner With VPCa and Self-Care Catalysts
31 Aug 2021 //
BUSINESSWIRE
Massive Bio, veterans nonprofit to boost prostate cancer studies
31 Aug 2021 //
FIERCEBIOTECH
xCures Partners With Massive Bio to Help Advanced Cancer Patients
29 Jun 2021 //
BUSINESSWIRE
